on
12.12.08
with
0 comments
Know the pathology, clinical manifestations, classification, and prognosis of lupus nephritis
- Class I – normal kidney
- Class II –Minimal/Mesangial Lupus Nephritis
- Earliest and mildest form of renal involvement
- Characterized by mesangial deposits of Ig and C3
- Proteinuria and hematuria present
- Nephrotic syndrome and renal insufficiency are very uncommon
- EM – IC deposits in mesangium
- IF – appears similar to IgA
- Class IIA – mesangial proliferative change
- Class IIB – no proliferative change
Class III – Focal proliferative Lupus Nephritis
- Proliferative changes present in <50%>
- ALL glomeruli have immune deposits of IgG, IgA, C3, and often IgM and fibrin-related Ags – seen on IF
- Mainly mesangial deposits with occasional subendothelial deposits (seen on EM – most reliable predictor of progression)
- All patients show proteinuria, but nephrotic syndrome and renal insufficiency are rare
- Hypocomplementemia more severe
- Long-term prognosis is good, but there is a high incidence of transformation to class IV
Class IV – Diffuse Proliferative Lupus Nephritis
- Most common and most severe form
- Proliferation seen in >50% of glomeruli, with crescent formation and necrosis common
- Extensive mesangial and subendothelial deposits
- Nephrotic range proteinuria
- Renal function decreased in 75% of patients at presentation
- Hypocomplementemia, high levels of anti-DNA Ab, and circulating Igs present in most patients
- Long-term survival rate is ~75% past five years
- Best prognosis is with those who show remission of nephrotic syndrome and normalization of serologic parameters achieved w/in 1 year of starting therapy
Class V
- Occurs in ~15% of SLE patients – hard to distinguish from idiopathic MN on LM
- IF – all sorts of Ig – contrast to idiopathic MN
- EM – other deposit sites in addition to those normally associated w/ MN
- May have undetectable levels of anti-DNA Ab at presentation
- Long-term prognosis about the same as with II (good)
Category:
Pathology Notes
POST COMMENT
0 comments:
Post a Comment